Results 11 to 20 of about 181,836 (188)

Ocular myasthenia gravis: Side effect of urografin

Heart India, 2016
Ocular myasthenia gravis is an autoimmune disorder of the neuromuscular junction. Diplopia and ptosis are common symptoms at the onset of ocular myasthenia gravis. It may occur due to the antibodies developed against various drugs.
Nitin Modi, Siddhant Jain, Mahendra Tilkar, Narayan Chandra Sarkar   +3 more
doaj   +2 more sources

Ocular myasthenia gravis: A review

Indian Journal of Ophthalmology, 2014
Myasthenia gravis (MG) is a disease that affects the neuro-muscular junction resulting in classical symptoms of variable muscle weakness and fatigability. It is called the great masquerader owing to its varied clinical presentations.
Akshay Gopinathan Nair, Preeti Patil-Chhablani, Devendra V Venkatramani, Rashmin Anilkumar Gandhi   +3 more
doaj   +2 more sources

Ocular myasthenia gravis in a setting of thyrotoxicosis

Indian Journal of Endocrinology and Metabolism, 2013
Ocular myasthenia gravis in conjunction with thyroid disorders, although rare, has been reported in the past. However, the similarity in the presentation of both the entities and the tendency of myasthenia gravis to get overlooked easily, even by ...
Sarabjeet Chhabra, B C Pruthvi
doaj   +2 more sources

Frontalis sling procedure for ocular myasthenia gravis

Clinical Ophthalmology, 2012
Shinichi Asamura1, Hirohiko Kakizaki2, Mitsuhiro Enjyo1, Takahiro Hashimoto1, Noritaka Isogai11Department of Plastic and Reconstructive Surgery, Kinki University School of Medicine, Osakasayama, Osaka, Japan; 2Department of Ophthalmology, Aichi Medical ...
Isogai N, Hashimoto T, Enjyo M, Kakizaki H, Asamura S   +4 more
doaj   +1 more source

Unilateral ocular myasthenia gravis-A case report

Indian Journal of Ophthalmology, 1990
Unilateral ocular myasthenia gravis is being reported. He had significant involvement of one eye with no involvement of the fellow eye.
Chouhan Jugal, Soni Tara, Mishra Y
doaj   +1 more source

Diagnosing Myasthenia Gravis With Repetitive Ocular Vestibular Evoked Myogenic Potentials

Frontiers in Neurology, 2020
Timely and accurate diagnosis of myasthenia gravis, particularly in patients with fluctuating, isolated ocular involvement, remains challenging. Serological antibody testing and repetitive nerve stimulation of peripheral muscles usually have low ...
Magdalena A. Wirth, Magdalena A. Wirth, Fabienne C. Fierz, Yulia Valko, Konrad P. Weber, Konrad P. Weber   +5 more
doaj   +1 more source

Quality of life in purely ocular myasthenia in Japan [PDF]

, 2014
Background: Since there has been no conclusive evidence regarding the treatment of ocular myasthenia, treatment guidelines were recently issued by the European Federation of Neurological Societies/European Neurological Society (EFNS/ENS).
Murai, Hiroyuki, Shigeaki Suzuki, Motomura, Masakatsu, Emiko Tsuda, Shunya Nakane, Nagane, Yuriko, Masuda, Masayuki, Shingo Konno, Suzuki, Shigeaki, Tsuda, Emiko, Konno, Shingo, Hiroyuki Murai, Imai, Tomihiro, Suzuki, Norihiro, Tomihiro Imai, Oji, Satoru, Nakane, Shunya, Yuriko Nagane, Norihiro Suzuki, Utsugisawa, Kimiaki, Satoru Oji, Masayuki Masuda, Masakatsu Motomura, Kimiaki Utsugisawa   +23 more
core   +2 more sources

Clinical predictors for the prognosis of myasthenia gravis

BMC Neurology, 2017
Background Clinical predictors for myasthenia gravis relapse and ocular myasthenia gravis secondary generalization during the first two years after disease onset remain incompletely identified.
Lili Wang, Yun Zhang, Maolin He
doaj   +1 more source

Features of depression development in myasthenia gravis.

Medičnì Perspektivi, 2020
The relative risk of developing depression in myasthenia gravis is 2.14 times higher than in the general population. The features of depression in myasthenia patients remain poorly understood and need to be clarified.
O. I. Kalbus, S. O. Makarov, N. P. Shastun, O. V. Somilo, Yu. V. Bukreyeva   +4 more
doaj   +1 more source

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases [PDF]

Frontiers in Immunology
Ma T, Zhu Y, Zhu R.
exaly   +2 more sources